The Sonic Fund II, L.P. Issues Presentation Correcting Adverum’s Misstatements
The Sonic Fund II, L.P. currently holds approximately 6.8% of Adverum Biotechnologies' outstanding common stock (NASDAQ: ADVM).
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
The Sonic Fund II, L.P. (“Sonic”), which beneficially owns approximately
The presentation, entitled “Adverum’s Myths: Correcting the Record,” is available at: https://www.saveadverum.com/investor-materials.
Vote on the GREEN proxy card today
If you have any questions regarding your GREEN proxy card or need assistance in voting your shares, please contact |
Saratoga Proxy Consulting, LLC
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210426005486/en/